Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Cinder Invest in connection with an investment in Stureplansgruppen
Mandate

Vinge advises Cinder Invest in connection with an investment in Stureplansgruppen

March 19, 2021 Environmental Law M&A

Vinge is advising Cinder Invest in connection with their investment in Stureplansgruppen. The investment provides Stureplansgruppen with the preconditions to overcome the pandemic, to develop existing operations and to continue to create new guest experiences. Cinder Invest will own 20 per cent.

Cinder Invest is a joint venture between AFA, AMF, FAM together with the Wallenberg Foundations, the Fourth Swedish National Pension Fund and SEB. Cinder Invest will invest in viable Swedish companies in order to help them to overcome the adverse economic consequences of Covid-19.

Vinge's team primarily consisted of, among others, Johan Larsson, Ellinor Wargenbrant, Niclas Winnberg and Amanda Steen.

 

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026